Generics

Filter

Current filters:

None

Popular Filters

1126 to 1142 of 1142 results

Watson confirms Lumigan and Latisse patent challenges; favorable Sanctura ruling

05-04-2012

US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has confirmed that its subsidiary, Watson Laboratories,…

AllerganGenericsGenito-urinaryLatisseLegalLumiganOphthalmicsPatentsSanctura XRWatson Pharmaceuticals

Head of NAFDAC advocates 200 billion naira lifeline for Nigerian pharma firms

05-04-2012

The Director-General of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC),…

FinancialGenericsPharmaceuticalRest of the World

BASF and Catalent join forces to address NME bioavailability challenges

04-04-2012

Privately-held USA-based Catalent Pharma Solutions has joined forces with German drug giant BASF (BAS:…

BASFCatalent PharmaGenericsPharmaceuticalResearch

Poland breaking EU law by allowing unauthorized cheaper drugs

02-04-2012

Polish legislation authorizing the placing on the market of foreign medicinal products lacking authorization…

EuropeGenericsLegalMarkets & MarketingPharmaceuticalRegulation

Australian PBS prices slash in effect; clinical trial investment

02-04-2012

On April 1, 2012, in Australia, publicly funded generic medicines on the Pharmaceutical Benefits Scheme…

Asia-PacificGenericsPharmaceuticalPricingResearch

Lower drugs costs and insurance may help India achieve affordable medicines

01-04-2012

The next few years will spell considerable growth and change for the Indian health insurance industry,…

Asia-PacificGenericsHealthcarePharmaceuticalPricing

Horizon Pharma sues Par for infringing Duexis patent

29-03-2012

Horizon Pharma (Nasdaq: HZNP) has filed a patent infringement lawsuit in the US District Court for the…

DuexisGenericsHorizon PharmaLegalNeurologicalNorth AmericaPar PharmaceuticalPatents

Sanofi and Bayer consider Russian expansion, product launches

28-03-2012

Two European drug majors - France-based Sanofi (Euronext: SAN) and German company Bayer (BAY: DE) have…

BayerEuropeGenericsInsulinMarkets & MarketingPharmaceuticalSanofi

STADA Arz sets up subsidiary in Australia

27-03-2012

German generics drugmaker STADA Arzneimittel (SAZ: GR) has established a subsidiary based in Sydney,…

Asia-PacificGenericsMarkets & MarketingSTADA Arzneimittel

Consumer groups call for condemnation of ACTA independent of ECJ

27-03-2012

Health-related consumer groups Health Action International (HAI) Europe, Oxfam, Medecins Sans Frontieres…

EuropeGenericsGlobalLegalPatentsPharmaceuticalPoliticsRegulation

1126 to 1142 of 1142 results

Back to top